Introduction
Hepatitis-B antigen (HBAg), formerly called Australia antigen or hepatitis-associated antigen, has been found in many patients with chronic liver disease (Prince, 1971 ) but whether it is active in perpetuating liver damage in these cases is uncertain (Muller et al., 1971 ). We -therefore followed up 86 patients with chronic liver disease for an average period of 38 months to see what differences there were in the clinical course of thse who wee HBAgjpositive and those who were HBAg negative. In the HBAg-positive cases we also correlated the behaviour of the antigen with various aspects of the liver disease. This paper reports our findings.
Patients and Methods
Of the 86 patients studied 48 were men and 38 were women. In most of them liver disease was indicated by abnormal results of liver function tests done during the investigation of various non-specific complaints. A diagnosis of cirrhosis was made in 41 patients (including two cases of primary biliary cirrhosis) and of chronic hepatitis in 45. Sixteen of the latter had chronic active hepatitis (C.A.H.) and 29 chronic persistent hepatitis (C.P.H. 445 Autoantibodies (antinuclear factor, smooth muscle antibody, antimitochondrial antibody) were looked for in 34 of the chronic hepatitis patients and found in 14, seven of whom were HBAg-positive (table III) . There was no significant differenice (P > 005) in the incidence of autoantibodies between the HBAg-positive and HBAg-negative patients. Antigen persisting after an acute attack of viral hepatitis has been found to be associated with histological changes in the liver (Nielsen et al., 1971) . In cases of chronic liver disease HBAg has been persistently present for months and years (Wright et al., 1969; Bulkley et al., 1970; Nielsen et al., 1971; Selmair et al., 1971) though it may eventually disappear (Muller et al., 1971; Thomas et al., 1973) . Four of our patients with chronic hepatitis and four of those with cinihosis became HBAg-ogative 8 to 106 monthis after the onset of the disease. Reports differ on the prognostic significance of conversion to HBAg-negative. In some cases no change in the course of the disease was noted (Shulman et al., 1970; Nielsen et al., 1971; Selmair et al., 1971) while in others conversion seemed to precede a return to normal in the results of liver tests (Wright et al., 1969; Muller et al., 1971; Thomas et al., 1973) . In the four of our patients with chronic hepatitis who became HBAg-negative liver biopsy findings were normal after conversion in two, and in the other two there was no clinical or biochemical evidence of continuing liver damage. In the four patients with cirrhosis who became HBAg negative, on the other hand, the clinical course of the disease was unchanged. These findings support the view of Thomas et al. (1973) that disappearance of the antigen is of prognostic importance only in those cases in which liver damage is still reversible. In estalblished cirrhosis the disease process rather than persistence of the antigen determines the clinical course (Popper, 1971 (Muller et al., 1971; Thomas et al., 1973) and its reappearance has been associated with exacerbation of the disease (Wright et al., 1969; Demeulenaere, 1971; Gentilini et al., 1972) . Our further studies, however, show that this relation is inconstant and fortuitous.
